Home / Recalls / Sentara Infusion Services / D-0319-2023

D-0319-2023 Class II Terminated

Recalled by Sentara Infusion Services — Chesapeake, VA

Recall Details

Product Type
Drugs
Report Date
February 22, 2023
Initiation Date
December 27, 2022
Termination Date
February 20, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
111 bags

Product Description

TPN 107gm/AA, 200gm/DEX, 50gm/LIP 2250mL, (b) 108GM/AA, 330GM/DEX 3000ML, (c) 108GM/AA, 330GM/DEX, 60GM/LIP 3000ML, (d) 37GM/AA, 160GM/DEX 1450ML, (e) 37GM/AA, 160GM/DEX, 25GM/LIP 1450ML, (f) 74-100GM OF PROTEIN B4197 74 Gm, (g) 75GM/AA, 200GM/DEX, 43GM/LIP 2500ML, (h) 90GM/AA ; 255GM/DEX ; 50GM/LIP 3500 ml, (i) 90GM/AA ; 255GMDEX 3500 ml, (j) TPN AA 100GM DEX: 320GM LIP: 50GM 2400ML, (k) TPN AA 30GM DEX: 145GM 1210ML, (l) TPN AA 30GM DEX: 145GM LIP: 35GM 1210ML, (m)TPN AA 42GM DEX: 432GM 2070ML, (n) TPN AA 50GM DEX: 130GM 2500ML, (o) TPN AA 55GM DEX:180GM 1000ML, (p) TPN AA 70GM DEX:290GM 2100ML, (q) TPN AA 70GM DEX:290GM 2500ML, (r) TPN AA 80GM DEX:200GM 1900ML, (s) TPN AA 80GM DEX:200GM LIP:38GM 1900ML, (t) TPN AA 30GM ; DEX 82GM ; IN 890 ml, (u) TPN AA 30GM ; DEX 82GM ; LIP 18GM IN 890 ml, Rx Only, use with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320

Reason for Recall

Lack of sterility assurance

Distribution Pattern

Dispensed to Patients Nationwide.

Code Information

Beyond Use Date: December 24-31, 2022

Other recalls by Sentara Infusion Services

  • D-0316-2023 Class II — Sodium Chloride 0.9 % (a) 100ML (MAGNESIUM) (b) 69.3ML, (c) 71.4ML, (d) 77.7ML, (December 27, 2022)
  • D-0303-2023 Class II — MEROPENEM (a) 1000MG IN NS 250ML, (b) 2GM IN NS 100ML, (c) 500mg IN NS 125ML, an (December 27, 2022)
  • D-0272-2023 Class II — 0.9% Sodium Chloride, used as a diluent or hydration, packaged volume of (a)100 (December 27, 2022)
  • D-0324-2023 Class II — VITAMIN K(PHYTONADIONE) 2.5MG(0.25ML) SYRINGE, Rx only, Sentara Home Infusion Ph (December 27, 2022)
  • D-0307-2023 Class II — Milrinone (a) 104MG IN 0.45% NS 130ML,(b) 108MG IN 0.45% NS 135ML, (c) 120MG IN (December 27, 2022)
  • D-0294-2023 Class II — GANCICLOVIR ( CYTOVENE) (a)1480MG IN NS 296ML, (b) 740 MG IN NS 336 ML, antivira (December 27, 2022)
  • D-0323-2023 Class II — VANCOMYCIN (a)700 MG NS 140ML, (b) 1000MG IN NS 200ML, abtibiotic, Rx only, use (December 27, 2022)
  • D-0302-2023 Class II — LEVOTHYROXINE 25MCG IN NS 1.25ML SYRINGE, Thyroid, Rx Only, Sentara Home Infusio (December 27, 2022)
  • D-0299-2023 Class II — KYTRIL 350MCG IN 3.5ML NS SYRINGE, antimetic, Rx Only, Sentara Home Infusion Pha (December 27, 2022)
  • D-0289-2023 Class II — Diphenhydramine 18mg in 3.6ML NS SYRINGE, antihistamine, Rx Only, Sentara Home I (December 27, 2022)